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Objectives. This study assessed the effects of inhibition of nitric
oxide synthesis on epicardial human coronary arteries and on
coronary flow velocity during baseline conditions and during
atrial pacing.
Background. Epicardial coronary artery dilation occurs in
response to an increase in heart rate. It is not known whether the
dilation of both angiographically normal and diseased epicardial
coronary arteries during atrial pacing is nitric oxide dependent in
humans.
Methods. The effects of an intracoronary infusion (4 mmol/min
for 8 min) of NG-monomethyl-L-arginine (LNMMA), an inhibitor
of nitric oxide synthesis, was studied in 16 patients with coronary
artery disease and in 6 patients with normal coronary arterio-
grams. In all patients atrial pacing was performed during normal
saline and during LNMMA infusion. The lumen diameter of
epicardial coronary arteries was assessed by quantitative angiog-
raphy, and changes in blood flow velocity were measured with a
Doppler catheter.
Results. During saline infusion a significant increase in the
lumen diameter of the proximal (p < 0.05) and distal (p < 0.01)
segments of both normal and diseased arteries occurred during
atrial pacing. No significant lumen diameter changes occurred in
either group when atrial pacing was performed during LNMMA
infusion. Stenosis diameter decreased during LNMMA infusion
but did not change with atrial pacing either during saline infusion
or during LNMMA infusion. The mean percent change in coronary
blood flow with atrial pacing was less (p < 0.05) during LNMMA
infusion than during saline infusion in both groups.
Conclusions. These findings confirm that epicardial coronary
artery dilation induced by pacing is nitric oxide dependent. Nitric
oxide production contributes to the vasomotor tone of coronary
resistance vessels. Nitric oxide is produced at the site of athero-
matous stenosis but is unaffected by pacing.
(J Am Coll Cardiol 1997;29:1256–62)
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During exercise and atrial pacing coronary blood flow in-
creases as a result of the microvascular dilation, which is
associated with increased myocardial work (1–4). This micro-
vascular dilation is probably due to release of metabolites from
the myocardium, and adenosine has been proposed as one
possible mediator (5–7). Whether microvascular nitric oxide
production is involved is unknown. However, the consequent
increase in coronary blood flow, whether related to exercise or
to atrial pacing, causes dilation of the epicardial coronary
arteries by a mechanism which experimental studies have
shown involves nitric oxide (8–10). In addition to the effects of
increased heart work during exercise, the epicardial coronary
artery tone is also influenced directly by autonomic nerve
activity and circulating vasoactive substances (11,12). The role
of nitric oxide in microvascular and epicardial coronary artery
vasomotor changes, associated with increased myocardial work
in humans, is unclear. Furthermore, there is little information
on the effects of coronary artery disease with regard to nitric
oxide–mediated coronary vasomotor changes in humans. Nitric
oxide is synthesized in vascular endothelial cells from the
amino acid L-arginine by the constitutive form of the enzyme
nitric oxide synthase (13). Synthesis of nitric oxide by this
enzyme can be competitively inhibited by administration of the
arginine analogue NG-monomethyl-L-arginine (LNMMA)
(14,15), and this provides a means of investigating the role of
nitric oxide production by blood vessels. A recent study (16) in
patients with normal or near normal epicardial coronary
arteries showed that during metabolic stimulation with atrial
pacing, nitric oxide contributes significantly to microvascular
dilation and is almost entirely responsible for the epicardial
vasodilation. However, these investigators did not examine the
effects of inhibition of nitric oxide during atrial pacing in
patients with coronary artery disease and stable angina.
To investigate whether nitric oxide mediates the coronary
vasodilation associated with increased myocardial work in
humans and to study the effects of disease, we have measured
epicardial coronary artery diameter and coronary blood flow
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velocity during atrial pacing with and without intracoronary
LNMMA infusion.
Methods
Study group. Sixteen patients (15 men and 1 woman, mean
age 56 6 8 years) with chronic stable angina, coronary artery
disease and a positive treadmill exercise test result ($0.1 mV
ST segment depression at 5 to 7 metabolic equivalents using
the modified Bruce protocol) and 6 patients (3 men and 3
women, mean age 50 6 6 years) with atypical chest pain,
angiographically normal smooth coronary arteries and risk
factors for coronary artery disease were studied. Their clinical
characteristics are listed in Table 1. Patients were excluded
from the study if they had diabetes mellitus, a history of
coronary spasm, recent myocardial infarction (,6 months),
left ventricular hypertrophy (on echocardiography), three-
vessel coronary artery disease, left ventricular dysfunction (left
ventricular ejection fraction ,50%) or valvular heart disease.
The protocol was approved by the Research Ethics Commit-
tee, and each patient gave written, informed consent.
Study protocol. Antianginal medication was stopped 24 h
before the study. The patients were allowed to use sublingual
nitroglycerin as necessary, but no study was performed within
3 h of its administration. After the diagnostic coronary angio-
gram, an optimal radiographic projection was selected and
kept constant for subsequent angiograms. The artery studied
was chosen to comply with the Research Ethics Committee’s
requirements that coronary stenoses .70% be avoided. Eigh-
teen stenoses were examined.
Two electrocardiographic (ECG) leads were monitored
continuously throughout the study. All infusions were admin-
istered into the coronary artery through an 8F Judkins angio-
plasty guiding catheter. All patients received a single 5-min
infusion of 0.9% saline (2 ml/min), during which atrial pacing
at 100 beats/min was initiated after 2 min and increased to 120
beats/min after 3 min and to 140 beats/min after 4 min. When
all measurements had returned to baseline (3 min, on average),
a 4-min infusion of 4 mmol/min of LNMMA was administered
in saline (infusion rate 2 ml/min) using a syringe pump. After
an interval of 5 min, another 4-min infusion of 4 mmol/min of
LNMMA was administered (infusion rate 2 ml/min), during
which pacing at 100 beats/min was initiated after 1 min and
increased to 120 beats/min after 2 min and to 140 beats/min
Abbreviations and Acronyms
ANOVA 5 analysis of variance
ECG 5 electrocardiogram, electrocardiographic
EDRF 5 endothelium-derived relaxing factor
LNMMA 5 NG-monomethyl-L-arginine
Table 1. Clinical Characteristics of Normal Subjects and Patients With Stable Angina
Subject
No.
Age (yr)/
Gender Hypertension
Smoking
Status
Cholesterol
Level (mg/dl) Coronary Artery Disease*
Patients With Coronary Artery Disease
1 68/M 1 2 206 RCA (40%),† LCx (85%), LCx (74%)
2 60/M 1 2 254 LCx (30%),† LCx (29%),† RCA (84%), RCA (42%)
3 57/M 2 2 285 LAD (51%),† RCA (68%), RCA (44%)
4 58/M 1 1 195 LAD (46%),† LCx (54%)†
5 60/M 2 1 268 LCx (31%),† LCx (26%),† RCA (80%)
6 56/M 2 2 211 LCx (22%),† RCA (50%)
7 47/M 1 1 208 LAD (54%),† LCx (69%),† RCA (100%)
8 61/M 2 1 183 LAD (50%)
9 47/M 2 1 260 LAD (38%),† RCA (32%)
10 60/M 2 2 187 RCA (40%),† LAD (80%)
11 70/M 2 2 348 LAD (51%),† LCx (64%),† LCx (67%),† RCA (55%)
12 58/M 2 1 297 LCx (50%),† RCA (61%)
13 52/M 2 2 205 RCA (30%), RCA (51%)
14 60/M 2 2 194 LAD (80%)
15 38/M 2 1 180 RCA (44%), RCA (47%), RCA (51%)
16 50/F 1 1 305 LCx (45%),† RCA (20%)
Normal Subjects
1 52/M 2 1 288 Normal CA
2 51/F 2 2 202 Normal CA
3 50/F 1 2 194 Normal CA
4 48/M 2 2 227 Normal CA
5 39/M 2 2 340 Normal CA
6 59/F 2 2 255 Normal CA
*Coronary stenosis severity (%lumen diameter reduction) in parentheses. †Stenoses studied. 1 5 present; 2 5 absent; CA 5 coronary arteries; LAD 5 left
anterior descending coronary artery; LCx 5 left circumflex coronary artery; RCA 5 right coronary artery.
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after 3 min (Fig. 1). Finally, an intracoronary bolus dose of
nitroglycerin (250 mg in 2 ml of saline) was administered.
Femoral artery pressure and heart rate were recorded before
pacing and during each pacing increment, during LNMMA
infusion alone and 2 min after nitroglycerin administration.
Angiography was performed with a hand injection of 6 to 8 ml
of nonionic contrast medium at baseline, at the end of the first
LNMMA infusion, before the second LNMMA infusion, im-
mediately before initiation of pacing, during the last 15 s of
pacing at 140 beats/min and 2 min after nitroglycerin (Fig. 1).
A maximal pacing rate of 140 beats/min was achieved in each
patient without the development of second-degree atrioven-
tricular block. Before each angiogram, the catheter was emp-
tied to avoid bolus administration of the infusate.
In a separate study (17), we examined the effects of
incremental doses of 2, 4, 8 and 16 mmol/min of LNMMA in
patients with coronary artery disease, and we found no signif-
icant differences in coronary artery lumen diameter reduction
between 4 mmol/min (total cumulative dose of 24 mmol) and
16 mmol/min (total cumulative dose of 120 mmol) in proximal
(21.3 6 1.0% vs. 22.9 6 1.5%, respectively, p 5 0.15) and
distal (26.8 6 1.01% vs. 210.9 6 2.6%, respectively, p 5 0.14)
segments of diseased vessels. Therefore, we chose to infuse the
dose of 4 mmol/min (total cumulative dose of 32 mmol).
Measurements of coronary blood flow velocity. In 10 patients
(5 patients with coronary artery disease and 5 control subjects)
mean and phasic blood flow velocity signals were obtained
using a 20-MHz Doppler crystal-tipped 8F Judkins catheter
positioned proximal in the left (n 5 8) or right coronary artery
(n 5 2) proximal to the diseased segments, as previously
described (18). The percent increase in mean blood flow
velocity during atrial pacing was calculated. The velocity
changes were corrected for changes in epicardial coronary
artery segment diameter by calculating flow volume as the
product of velocity and the cross-sectional area of the epicar-
dial artery at the sampling point of the Doppler catheter,
assuming a uniform velocity over the cross section of the vessel.
Quantitative coronary angiography. The arterial segments in
each frame were analyzed blindly in random order using
quantitative computerized analysis with an automated edge
contour detection analysis system (CAAS, version 2V2; Pie
Data Medical) (19,20). End-diastolic frames from each arte-
riogram were selected for analysis. The angiographic catheter
was used as a scaling device, and this, together with
pincushion-distortion correction, allowed the diameters to be
recorded as absolute values (expressed in millimeters). Re-
corded variables at baseline, during saline, during saline with
pacing, during LNMMA, during LNMMA with pacing and after
nitrate administration were: 1) the diameter of angiographi-
cally normal proximal and distal segments: the proximal left
anterior descending coronary artery diameter was measured
just beyond the origin of the artery and the distal diameter was
measured just distal to the second diagonal branch; the
proximal left circumflex coronary artery diameter was mea-
sured just beyond the origin of the artery and the distal
diameter just beyond the origin of the second obtuse marginal
branch; the proximal right coronary artery diameter was
measured just beyond the origin of the artery and the distal
diameter just beyond the posterior descending branch; and 2)
the minimal lumen diameter at the site of coronary stenosis
and the diameter of the angiographically normal adjacent
segment. Two proximal segments (one in the left circumflex
coronary artery, another in the left anterior descending coro-
nary artery) and at least two distal segments were selected for
analysis from each left coronary arteriogram.
Quantitative analysis of coronary arteriograms was carried
out by two independent observers who later reanalyzed the
films in blinded manner for reproducibility of the method. No
significant intraobserver or interobserver variability was found
(analysis of variance [ANOVA] by F 5 0.3, p 5 0.75).
Statistical analysis. Data are expressed as mean value 6
SEM. Analysis of variance and the Scheffe F test for repeated
measures were used to compare serial changes in heart rate
and blood pressure and in the diameter of coronary stenoses.
To test for differences in the response of proximal and distal
segments to atrial pacing with and without LNMMA, two-way
ANOVA for repeated measures was applied. Associations
between serum cholesterol and responses to atrial pacing and
to LNMMA were assessed by performing linear regression
analysis and calculation of a correlation coefficient. The Stu-
dent t test was used to compare paired and unpaired data
between groups and the responses to nitroglycerin and
LNMMA. A p value ,0.05 (two-tailed) was considered statis-
tically significant.
Results
Hemodynamic measurements. Clinical characteristics in-
cluding age, gender, blood pressure, smoking status and angio-
graphic findings are presented in Table 1. During the LNMMA
infusion, the heart rate remained unchanged, but there was a
significant rise in systolic blood pressure (Table 2). There was
no significant difference in baseline heart rate before saline
infusion compared with that before LNMMA infusion (71 6
1.1 and 73 6 1.5 beats/min, respectively, p 5 0.07). Four
patients (one with normal coronary arteries) developed chest
pain with pacing during LNMMA infusion, but no ECG
changes were detected.
Changes in epicardial coronary arteries and stenoses.
Patients with coronary artery disease. After saline infusion there
was no significant change in the lumen diameter of the
Figure 1. Flow diagram illustrating the study protocol. A 5 angio-
gram; GTN 5 nitroglycerin.
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proximal and distal segments of the epicardial coronary arter-
ies (Table 3). A significant increase in the lumen diameter of
the angiographically normal proximal (p , 0.01) and distal
(p , 0.01) segments occurred during atrial pacing performed
during the saline infusion, but no change occurred at the site of
stenosis (Table 3). At rest after the LNMMA infusion, there
was a significant reduction in the lumen diameter of distal
segments (p , 0.01) and stenoses (p , 0.01) (Table 3). No
significant change in the lumen diameter, compared with
baseline values of the proximal and distal segments or of the
stenoses, occurred during atrial pacing during the LNMMA
infusion (Table 3). Significant dilation (p , 0.01) of all
segments and stenoses was found after administration of
nitrates, and the percent changes were greater in the distal
than in the proximal segments (p , 0.05) (Table 3). The mean
change in lumen diameter was significantly (p , 0.01) greater
in proximal and distal segments during pacing and saline
infusion than during pacing and LNMMA infusion (Fig. 2).
Patients with normal coronary arteriograms. After saline
infusion there was no significant change in the lumen diameter
of the proximal and distal segments of the epicardial coronary
arteries (Table 3). A significant increase in the lumen diameter
of the proximal (p , 0.05) and distal (p , 0.01) segments
occurred during atrial pacing performed during the saline
infusion (Table 3). The distal segments showed greater percent
dilation in response to atrial pacing than did those of patients
with coronary artery disease (15.0 6 2.0% vs. 9.4 6 1.2%,
respectively, p , 0.05). At rest after the LNMMA infusion,
there was a significant reduction in lumen diameter compared
with baseline values of both the proximal (p , 0.01) and distal
segments (p , 0.01) (Table 3). No change in the lumen
diameter of the proximal and distal segments occurred during
atrial pacing and LNMMA infusion, compared with saline or
LNMMA infusions alone (Table 3). The mean change in lumen
diameter was significantly (p , 0.01) greater in distal segments
during pacing and saline infusion than during pacing and
LNMMA infusion (Fig. 2).
The mean serum cholesterol level was 237 6 13 mg/dl in
patients with coronary artery disease and 251 6 23 mg/dl in
patients with normal angiograms (p 5 0.58). The response to
LNMMA in patients with a serum cholesterol .220 mg/dl was
similar to that in patients with a cholesterol level #220 mg/dl
(proximal segments: 22.49 6 1.06% vs. 22.32 6 1.29%, p 5
0.95; distal segments: 26.09 6 1.14% vs. 26.59 6 1.59%,
respectively, p 5 0.8). There was no significant correlation
between cholesterol level and response to LNMMA in either
proximal (r 5 0.06, p 5 0.74) or distal segments (r 5 0.02, p 5
0.90). Furthermore, there was no significant correlation be-
tween serum cholesterol level and response to atrial pacing in
either proximal (r 5 0.13, p 5 0.44) or distal segments (r 5
0.16, p 5 0.12) (Fig. 3).
Changes in coronary velocity versus changes in coronary
blood flow. Saline infusion did not alter coronary velocity.
Pacing progressively increased coronary velocity. The mean
percent increases in coronary velocity with atrial pacing during
saline and during LNMMA infusion were 36 6 1.7% and 24 6
2.6%, respectively (p , 0.05) in patients with normal angio-
grams, and 29 6 5.6% and 25 6 5.3%, respectively (p 5 0.33)
Table 2. Changes in Systolic Blood Pressure (mm Hg) in Normal Subjects and in Patients With
Stable Angina
Baseline
Saline1Pacing
at 140 beats/min LNMMA
LNMMA1Pacing
at 140 beats/min
Normal subjects 125 6 3.5 128 6 3.9 136 6 2.9* 137 6 2.9*
Patient with stable angina 132 6 3.9 135 6 5.3 140 6 3.8* 141 6 4.6*
*p , 0.01 compared with baseline value. Data presented are mean value 6 SEM. LNMMA 5 NG-monomethyl-L-
arginine.
Table 3. Mean Diameter Changes of Proximal and Distal Segments and Coronary Stenoses in Response to Atrial Pacing During Saline and
During Intracoronary NG-Monomethyl-L-Arginine (4 mmol/min)
Minimal Lumen Diameter (mm)
Saline
Saline1Pacing
(140 beats/min) LNMMA
LNMMA1Pacing
(140 beats/min) Nitroglycerin
Stable angina
Proximal (n 5 26) 3.27 6 0.13 (0.1 6 0.4%) 3.44 6 0.15 (5.6 6 1.0%)* 3.19 6 0.13 (21.9 6 1.0%) 3.21 6 0.15 (21.9 6 1.7%)§ 3.62 6 0.14 (12.5 6 1.6%)‡
Distal (n 5 37) 1.49 6 0.05 (0.3 6 0.6%) 1.61 6 0.05 (9.4 6 1.2%)* 1.39 6 0.05 (26.0 6 1.3%)‡ 1.45 6 0.05 (21.6 6 1.3%)§ 1.73 6 0.06 (19.8 6 2.1%)‡
Stenoses (n 5 18) 1.55 6 0.10 (0.4 6 0.6%) 1.58 6 0.11 (2.0 6 1.3%) 1.50 6 0.11 (22.8 6 1.0%)‡ 1.56 6 0.11 (0.6 6 1.1%) 1.77 6 0.14 (13.5 6 1.9%)‡
Normal CAs
Proximal (n 5 10) 2.89 6 0.20 (1.1 6 0.5%) 3.06 6 0.20 (7.1 6 1.7%)† 2.77 6 0.22 (23.8 6 1.3%)‡ 2.88 6 0.22 (20.8 6 1.6%) 3.33 6 0.22 (16.7 6 3.3%)‡
Distal (n 5 18) 1.19 6 0.05 (1.6 6 0.6%) 1.34 6 0.05 (15.0 6 2.0%)* 1.09 6 0.04 (27.1 6 1.3%)‡ 1.17 6 0.06 (20.6 6 1.6%)§ 1.38 6 0.06 (17.4 6 2.1%)‡
*p , 0.01 and †p , 0.05 compared with saline infusion (two-way analysis of variance). ‡p , 0.01 compared with saline infusion. §p , 0.01 compared with pacing
during saline infusion (two-way analysis of variance). Data presented are mean value 6 SEM (% change from baseline). CAs 5 coronary arteries; LNMMA 5
NG-monomethyl-L-arginine; n 5 number of coronary segments.
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in patients with coronary artery disease. The mean percent
increases in coronary blood flow with atrial pacing during
saline and during LNMMA infusion were 55 6 4.6% and 30 6
2.8%, respectively, (p , 0.05) in patients with normal angio-
grams and 38 6 8.1% (p , 0.05 vs. normal angiograms) and
26 6 9.1% (p , 0.05 vs. pacing during saline), respectively, in
patients with coronary artery disease.
Discussion
In this study we examined the effects of saline and LNMMA
infusions with and without atrial pacing in patients with
coronary artery disease and in patients with normal coronary
arteriograms and risk factors for coronary artery disease. The
results show that coronary stenoses constrict in response to
LNMMA but did not dilate in response to pacing. This suggests
that nitric oxide production is preserved at the stenosis site but
is not stimulated by an increase in lumen blood flow velocity in
the epicardial vessel. The results also show that angiographi-
cally normal proximal and distal segments of normal and
diseased epicardial coronary arteries dilate in response to
atrial pacing. The distal segments of normal arteries dilate
more than those of diseased arteries. No significant dilation of
any segment occurred in response to atrial pacing during
LNMMA infusion. LNMMA infusion alone caused slight con-
striction of stenoses and all other segments except the proximal
segments of patients with coronary artery disease. The pacing-
related blood flow increase was reduced by LNMMA infusion
in normal subjects and in patients with coronary artery disease.
Flow-mediated dilation and endothelial function. Physical
exercise induces an increase in both cardiac sympathetic nerve
activity and circulating catecholamine levels (11,12,21). The
resulting increase in heart rate and contractility increases
myocardial oxygen demand and induces metabolic dilation of
small resistance coronary arteries to augment blood flow and
oxygen supply to satisfy this increased demand (5). Simulta-
neous dilation of large epicardial arteries occurs, and previous
studies (4,9,22) have suggested that this dilation of the large
epicardial coronary arteries is a consequence of the microvas-
cular dilation. Its mechanism is probably the release of
endothelium-derived relaxing factors (EDRFs) due to in-
creased shear stress related to increased blood flow velocity.
Schwartz et al. (23) have obtained evidence that an increase in
shear stress secondary to an exercise-induced increase in
coronary blood flow enhances the production of EDRF(s) by
demonstrating that a flow-limiting stenosis prevented the
exercise-induced dilation of the epicardial coronary segment
artery proximal to the stenosis. Previous studies in vitro and in
vivo in animals (3,24 –26) have demonstrated that flow-
mediated dilation is abolished by removing the endothelium of
epicardial arteries. It has been shown that the epicardial
coronary artery dilation in response to the increase in blood
flow after temporary coronary artery occlusion is mediated
through an endothelium-dependent mechanism (4,8).
The present study shows that LNMMA inhibits pacing-
induced epicardial artery dilation. This is consistent with a
recent report by Quyyumi et al. (16) who found that LNMMA
inhibits the pacing related dilation of angiographically normal
or near normal epicardial coronary arteries and indicates that
nitric oxide is the mediator of this dilation as LNMMA has
been shown to specifically inhibit the basal nitric oxide pro-
duction and acetylcholine stimulated production of nitric oxide
(13,14,27). The findings of Quyyumi et al. (16) and those of our
Figure 2. Bar graph showing mean results of diameter changes
expressed as percent diameter change from saline or LNMMA (at
baseline) after atrial pacing in patients with coronary artery disease
(CAD) and with normal angiograms (normals). The mean change in
lumen diameter was significantly (p , 0.01) greater in both groups
during pacing and saline infusion than during pacing and LNMMA
infusion. Solid bars 5 percent diameter change from saline; striped
bars 5 percent diameter change from LNMMA.
Figure 3. Correlation between serum choles-
terol level (mg/dl) and percent diameter
change from saline after atrial pacing for
proximal segments (left panel) and distal seg-
ments (right panel). Linear regression analysis
showed no significant correlation between
these two variables.
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study support the hypothesis that a functional endothelium is
essential for epicardial coronary artery dilation in response to
increased myocardial work. The greater distal segment dilation
with atrial pacing in normal subjects compared with that in
patients with coronary artery disease could indicate relative
impairment of endothelial function in those with coronary
artery disease.
Nitric oxide production at the stenotic site. The finding in
our study which is of particular interest is that coronary
stenoses constrict slightly in response to LNMMA, indicating
that there is basal nitric oxide production at this site, but they
do not dilate with atrial pacing, indicating that nitric oxide
production is not stimulated by the pacing-induced increase in
coronary blood flow. A possible explanation for this is that
nitric oxide production at the site of stenosis is confined to
endothelium of the new microvessels in the wall of the artery
around the atheromatous plaque or to other cell types in the
vascular wall and are therefore not exposed to the increased
flow velocity in the lumen of the epicardial vessels. Such
neovascularization of atheromatous plaques is well docu-
mented, and a recent study (28) showed the presence of
inducible nitric oxide synthase in the neomicrovasculature. An
alternative explanation is that the residual endothelium lining
the lumen of the epicardial vessel is producing a maximal
amount of nitric oxide in the rest state or that its response to
stimulation has been severely impaired by disease. All seg-
ments, diseased and normal, including stenoses, responded to
nitroglycerin, an endothelium-independent dilator, indicating
the presence of functioning vascular smooth muscle.
In this study, as in another (29), constriction of coronary
stenoses was not observed during atrial pacing. This is in
contrast to the finding of a reduction in coronary blood flow
across stenoses during atrial pacing reported by Nabel et al.
(22). These apparently conflicting findings may be due to a
difference in the baseline severity of the stenoses studied.
Nabel et al. found constriction of stenoses .70%, but these
were excluded from our study. Furthermore, the mild stenoses
in our study did not dilate in response to pacing, and this is
consistent with the findings of Nabel et al. (22). The segments
that dilated in our study were angiographically normal. More-
over, the mechanisms of stenosis constriction are complex and
probably include passive collapse, neural reflexes and circulat-
ing catecholamines as well as abnormal synthesis and secretion
of endothelial factors including nitric oxide.
The inhibition of pacing-induced vascular dilation appears
to extend to the small coronary artery branches as LNMMA
infusion reduces the magnitude of pacing-related flow in-
creases, indicating an effect on coronary resistance vessels.
This finding is consistent with the results of Quyyumi et al.
(16), who also demonstrated a reduction in pacing-related flow
increase in their patients with angiographically normal or near
normal epicardial coronary arteries. The nature of these
studies does not allow an estimation of the precise size of
resistance vessels producing nitric oxide in response to pacing,
nor does it exclude other mediators of this response. Canty and
Schwartz (10) found in animal experiments that inhibition of
nitric oxide failed to affect the changes in mean coronary blood
flow during atrial pacing. Moreover, they showed that nitric
oxide–mediated epicardial artery dilation is more closely re-
lated to changes in pulse frequency than increases in mean
blood flow. This may have particular significance in the coro-
nary circulation owing to the systolic-diastolic variations in
epicardial flow.
Study limitations. The presence of nonobstructive coro-
nary artery disease undetected by coronary angiography cannot
be excluded in the control group. Both study groups included
several patients with hypercholesterolemia, but there were
more smokers in the coronary artery disease group and this
could have influenced their nitric oxide production. There
were more women in the control group than in the group with
coronary artery disease. The reduction of pacing-induced
epicardial vessel dilation by LNMMA could be partly explained
by the attenuated flow increase by LNMMA. It is possible that
the use of an intracoronary Doppler probe might have pro-
vided technically superior recordings; however, this could have
involved intracoronary instrumentation with no clinical indica-
tion. Although recent studies (16) have used a higher dose of
LNMMA, the dose of 4 mmol/min used in this study was
previously shown (17) to be sufficient to induce coronary
constriction of a similar degree to that observed at a dose of 16
mmol/min in proximal and distal segments. Furthermore, it
caused a significant rise in systolic blood pressure.
Conclusions. This study demonstrates that in both patients
with normal and abnormal coronary arteriograms epicardial
coronary artery dilation in response to atrial pacing is nitric
oxide dependent and a pacing-induced increase in coronary
blood flow is at least partly nitric oxide dependent. These
findings confirm that endothelial production of nitric oxide
extending to the resistance vessels is an essential component of
flow-mediated coronary artery epicardial vessel dilation. Nitric
oxide is produced at the site of stenosis, but its production is
not enhanced by an increase in blood flow velocity in the lumen
of the epicardial vessels.
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